Changes in gene expression in the intact human heart: Downregulation of α-myosin heavy chain in hypertrophied, failing ventricular myocardium

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2315-2324

  Lowes, Brian D ^b   Minobe, Wayne ^b   Abraham, William T ^b   Rizeq, Mona N ^b   Bohlmeyer, Teresa J ^b   Quaife, Robert A ^b   Roden, Robert L ^b   Dutcher, Darrin L ^b   Robertson, Alastair O ^b   Voelkel, Norbert F ^b   Badesch, David B ^b   Groves, Bertron M ^b   Gilbert, Edward M ^b   Bristow, Michael R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

Atrial natriuretic peptide; Sarcoplasmic reticulum Ca2+ ATPase; myosin heavy chain; adrenergic receptors; myosin heavy chain

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ATRIAL NATRIURETIC FACTOR; BETA 2 ADRENERGIC RECEPTOR; MESSENGER RNA; MYOSIN HEAVY CHAIN;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM;

EID: 0030685743     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119770     Document Type: Article

References (67)

1. Feldman, A.M., P.E. Ray, C.M. Silan, J.A. Mercer, W. Minobe, and M.R. Bristow. 1991. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 83:1866-1872.
2. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J. Clin. Invest. 85:305-309.
3. Brillantes, A.-M., P. Allen, T. Takahashi, S. Izumo, and A.R. Marks. 1992. Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ. Res. 71:18-26.
4. Saito, Y., K. Nakao, H. Arai, K. Nishimura, K. Okumura, K. Obata, G. Takemura, H. Fujiwara, A. Sugawara, T. Yamada, et al. 1989. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J. Clin. Invest. 83:298-305.
5. 2+ ATPase in failing and nonfailing human myocardium. Circ. Res. 75:434-442.
6. 1-adrenergic receptors in the failing human heart. Circulation. 87:454-463.
7. 1 receptor mRNA abundance in the failing human heart. J. Clin. Invest. 92:2737-2745.
8. 2+ exchanger in end-stage human heart failure. Circ. Res. 75:443-453.
9. 1 receptor down-regulation in heart failure. Circ. Res. 59:297-309.
10. 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy. J. Cardiovasc. Pharmacol. 8:1235-1242.
11. White, M., R.J. Wiechmann, R.L. Roden, M.B. Hagan, M.M. Wollmering, J.D. Port, E. Hammond, W.T. Abraham, E.E. Wolfel, J. Lindenfeld, et al. 1995. Cardiac β-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury: evidence for catecholamine-mediated myocardial damage. Circulation. 92:2183-2189.
12. Ladenson, P.W., S.I. Sherman, K.L. Baughman, P.E. Ray, and A.M. Feldman. 1992. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc. Natl. Acad. Sci. USA. 89:5251-5255.
13. 1-adrenergic receptor mRNA in heart failure. J. Am. Coll. Cardiol. 27:146-154.
14. Wang, A.M., M.V. Doyle, and D.F. Mark. 1989. Quantitation of mRNA by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA. 86:9717-9721.
15. Greenberg, B.D., G.H. Bencen, J.J. Seilhamer, J.A. Lewicki, and J.C. Fiddes. 1984. Nucleotide sequence of the gene encoding human atrial natriuretic factor precursor. Nature (Lond.). 312:656-658.
16. 2+-ATPase gene. J. Biol. Chem. 263:15024-15031.
17. 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA. 84:7920-7924.
18. Kobilka, B.K., T. Frielle, H.G. Dohlman, M.A. Bolanowski, R.A. Dixon, P. Keller, M.G. Caron, and R.J. Lefkowitz. 1987. Delineation of the intronless nature of the genes for the human and hamster beta-2-adrenergic receptor and their putative promoter regions. J. Biol. Chem. 262:7321-7327.
19. Kurabayashi, M., H. Tsuchimochi, I. Komuro, F. Takaku, and Y. Yazaki. 1988. Molecular cloning and characterization of human cardiac αa-and β-form myosin heavy chain complementary cDNA clones. J. Clin. Invest. 82: 524-531.
20. Brodde, O.-E., M. Khamssi, and H.R. Zerkowski. 1991. β-Adrenoceptors in the transplanted human heart: unaltered β-adrenoceptor density but increased proportion of β-adrenoceptors with increasing posttransplant time. Naunyn-Schmiedebergs Arch. Pharmacol. 344:430-435.
21. Loud, A.V., and P. Anversa. 1984. Morphometric analysis of biologic processes. Lab. Invest. 50:250-261.
22. Moulton, M.J., L.L. Creswell, F.F. Ungacta, S.W. Downing, and B.A. Szabó. 1996. Magnetic resonance imaging provides evidence for remodeling of the right ventricle after single-lung transplantation for pulmonary hypertension. Circulation. 94 [Suppl. II]:II-312-II-319.
23. Quaife, R.A., D. Lynch, B.E. Groves, N.F. Voelkel, E.M. Herrold, K. Wynne, M.R. Bristow, and D.B. Badesch. 1996. Elevated right ventricular circumferential wall stress inversely correlates with right ventricular systolic function in primary pulmonary hypertension. Circulation. 94(Suppl.):I-647. (Abstr.)
24. Konstam, M.A., S.R. Cohen, D.N. Salem, T.P. Conlon, J.M. Isner, D. Das, M.R. Zile, H.J. Levine, and P.C. Kahn. 1985. Comparison of left and right ventricular end-systolic pressure-volume relations in congestive heart failure. J. Am. Coll. Cardiol. 5:1326-1334.
25. Bristow, M.R. 1993. Changes in vascular and myocardial receptors in heart failure. J. Am. Coll. Cardiol. 22(Suppl. A):61A-71A.
26. Thorburn, A., J. Thorburn, S.-Y. Chen, S. Powers, H.E. Shubeita, J.R. Feramisco, and K.R. Chien. 1993. H-Ras-dependent pathways can activate morphological and genetic markers of cardiac muscle cell hypertrophy. J. Biol. Chem. 268:2244-2249.
27. Bristow, M.R., W. Minobe, R. Rasmussen, P. Larrabee, L. Skerl, J.W. Klein, F.L. Anderson, J. Murray, L. Mestroni, S.V. Karwande, M. Fowler, and R. Ginsburg. 1992. β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local, rather than systemic mechanisms. J. Clin. Invest. 89:803-815.
28. Bristow, M.R., F.L. Anderson, J.D. Port, L. Skerl, R.E. Hershberger, P. Larrabee, J.B. O'Connell, D.G. Renlund, K. Volkman, J. Murray, and A.M. Feldman. 1991. Differences in β-adrenergic neuroeffector mechanisms in ischemic vs. idiopathic dilated cardiomyopathy. Circulation. 84:1024-1039.
29. 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J. Am. Coll. Cardiol. 14:323-331.
30. Weiss, A., and L.A. Leinwand. 1996. The mammalian myosin heavy chain gene family. Annu. Rev. Cell Dev. Biol. 12:417-439.
31. Swynghedauw, B. 1986. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscles. Physiol. Rev. 66:710-730.
32. Barany, M. 1967. ATPase activity of myosin correlated with speed of muscle shortening. J. Gen. Physiol. 50:197-218.
33. Morkin, E. 1993. Regulation of myosin heavy chain genes in the heart. Circulation. 87:1451-1460.
34. Saez, L.J., K.M. Gianola, E.M. McNally, A. Feghali, A. Eddy, T.B. Shows, and L.A. Leinwand. 1987. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucl. Acids Res. 15:5443-5459.
35. Mercadier, J.J., P. Bouveret, L. Gorza, S. Schiaffino, W.A. Clark, R. Zak, B. Swynghedauw, and K. Schwartz. 1983. Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ. Res. 53:52-62.
36. Hirzel, H.O., C.R. Tuchschmid, J. Schneider, H.P. Krayenbuehl, and M.C. Schaub. 1985. Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy. Circ. Res. 57:729-740.
37. Gorza, L., J.J. Mercadier, K. Schwartz, L.E. Thornell, S. Sartore, and S. Schiaffino. 1984. Myosin types in the human heart: an immunofluorescence study of normal and hypertrophied atrial and ventricular myocardium. Circ. Res. 54:694-702.
38. Lompre, A.-M., J.J. Mercadier, C. Wisnewsky, P. Bouveret, C. Pantaloni, A. D'Albis, and K. Schwartz. 1981. Species-and age-dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Dev. Biol. 84: 286-290.
39. Schier, J.J., and R.S. Adelstein. 1982. Structural and enzymatic comparison of human cardiac muscle isolated from infants, adults, and patients with hypertrophic cardiomyopathy. J. Clin. Invest. 69:816-825.
40. Lompre, A.-M., K. Schwartz, A. Albis, G. Lacombe, N.V. Thiem, and B. Bwynghedauw. 1979. Myosin isozyme redistribution in chronic heart overload. Nature (Lond.). 282:105-107.
41. Nadal-Ginard, B., and V. Mahdavi. 1989. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J. Clin. Invest. 84:1693-1700.
42. Scheuer, J., A. Malhorta, C. Hirsch, J. Capasso, and T. Schaible. 1982. Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J. Clin. Invest. 70:1300-1305.
43. Nakao, K., W. Minobe, R. Roden, M.R. Brislow, and L.A. Leinwand. 1997. Myosin heavy chain gene expression in human heart failure. J. Clin Invest. 100:2362-2370.
44. Jones, W.K., I.L. Grupp, T. Doetschman, G. Grup, H. Osinska, T.E. Hewett, G. Boivin, J. Gulick, W.A. Ng, and J. Robbins. 1996. Ablation of the murine α myosin heavy chain gene leads to dosage effects and functional defects in the heart. J. Clin. Invest. 98:1906-1917.
45. Mahdavi, V., M. Periasmy, and B. Nadal-Ginard. 1982. Molecular characterization of two myosin heavy chain genes expressed in the adult heart. Nature (Lond.). 297:659-664.
46. 2+ exchanger in end-stage human heart failure. Circ. Res. 75:443-453.
47. Feldman, A.M., P.E. Ray, and M.R. Bristow. 1991. Expression of α-subunits of G proteins in failing human heart: a reappraisal utilizing quantitative polymerase chain reaction. J. Mol. Cell. Cardiol. 23:1355-1358.
48. Schwartz, K., K.R. Boheler, D.D.L. Bastie, A.-M. Lompre, and J.J. Mercadier. 1992. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol. 31):R364-R369.
49. Dorn, G.W., J. Robbins, N. Ball, and R.A. Walsh. 1994. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am. J. Physiol. 36:H400-H405.
50. Izumo, S., A.M. Lompre, R. Matsuoka, G. Koren, and K. Schwartz. 1988. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J. Clin. Invest. 79:970-977.
51. Lompre, A.-M., B. Nadal-Ginard, and V. Mahdavi. 1984. Expression of the cardiac ventricular α-and β-myosin heavy chain genes is developmentally and hormonally regulated. J. Biol. Chem. 259:6437-6446.
52. 1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J. Biol. Chem. 269:3775-3782.
53. Ito, H., S.C. Miller, M.E. Billingham, H. Akimoto, S.V. Torti, R. Wade, R. Gahlmann, G. Lyons, L. Kedes, and P.M. Torti. 1990. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. Proc. Natl. Acad. Sci. USA. 87:4275-4279.
54. Wiesner, R.J., H. Ehmke, J. Faulhaber, R. Zak, and C. Rüegg. 1997. Dissociation of left ventricular hypertrophy β-myosin heavy chain gene expression, and myosin isoform switch in rats after ascending aortic stenosis. Circulation. 95:1253-1259.
55. Goldspink, P.H., D.B. Thomason, and B. Russell. 1996. Beating affects the posttranscriptional regulation of α-myosin mRNA in cardiac cultures. Am. J. Physiol. 27(Heart Circ. Physiol. 40):H2584-H2590.
56. Sindwhani, R., F. Ismail-Beigi, and L.A. Leinwand. 1994. Post-transcriptional regulation of rat α cardiac myosin heavy chain gene expression. J. Biol. Chem. 269:3272-3276.
57. Margossian, S.S., H.D. White, J.B. Caulfield, P. Norton, S. Taylor, and H.S. Slayter. 1992. Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy: identification of a causal agent for impaired myocardial function. Circulation. 85:1720-1733.
58. Hajjar, R.J., and J.K. Gwathmey. 1992. Cross-bridge dynamics in human ventricular myocardium. Circulation. 86:1819-1826.
59. Alpert, N.R., and M.S. Gordon. 1962. Myofibrillar adenosine triphosphate activity in congestive heart failure. Am. J. Physiol. 202:940-946.
60. Pagani, E.D., A.A. Alousi, A.M. Grant, T.M. Older, S.W. Dziuban, and P.D. Allen. 1988. Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, and mitral valve insufficiency. Circ. Res. 63:380-385.
61. Alousi, A.A., A.M. Grant, J.R. Etzler, B.R. Cofer, J. Van der Bel-Kahn, and D. Melvin. 1990. Reduced cardiac myofibrillar Mg-ATPase activity without changes in myosin isoenzymes in patients with end-stage heart failure. Mol. Cell. Biochem. 96:79-88.
62. Solaro, R.J. 1992. Myosin and why hearts fail. Circulation. 85:1945-1947.
63. Takeda, N., H. Rupp, G. Fenchel, H.-E. Hoffmeister, and R. Jacob. 1985. Relationship between the myofibrillar ATPase activity of human biopsy material and hemodynamic parameters. Jpn. Heart J. 26:909-922.
64. Kawana, M., S. Kimata, and S. Hosoda. 1994. The changes in expression of cardiac myosin isozymes by the stimulation of the sympathetic nerve and thyroxine. In The Adapted Heart. N. Takeda and N.S. Dhalia, editors. Raven Press, New York. 393-401.
65. Clark, W.A., R.A. Chizzonite, A.W. Everett, M. Rabinowitz, and R. Zak. 1982. Species correlations between cardiac isoenzymes: a comparison of electrophoretic and immunologic properties. J. Biol. Chem. 257:5449-5454.
66. Pende, A., K.D. Mitchusson, C.T. DeMaria, B.C. Blaxall, W.A. Minobe, J.S. Sherman, G. Brewer, and J.D. Port. 1996. Regulation of the mRNA binding protein AUF1 by activation of the β-adrenergic receptor signal transduction pathway. J. Biol. Chem. 271:8493-8501.
67. Blaxall, B.C., A. Pende, G. Brewer, and J.D. Port. 1996. Differential affinities of the mRNA binding protein AUF1 for β-adrenergic receptor mRNAs. Cold Spring Harbor Symposium on Translational Control. p. 125.